Ceritinib is a prescription medication used in the treatment of non-small cell lung cancer (NSCLC). It is a type of targeted therapy called a kinase inhibitor, which works by blocking certain proteins in the body that help cancer cells grow and divide. Ceritinib is typically used when other treatments have failed. It is taken orally once a day. Common side effects include nausea, vomiting, diarrhea, and fatigue.
Ceritinib: A Targeted Therapy for Specific Cancers
Ceritinib, sold under the brand name Zykadia, is a prescription medication classified as a tyrosine kinase inhibitor (TKI). It's used to treat specific types of non-small cell lung cancer (NSCLC). Here's a detailed description of its key characteristics:
Function:
- Tyrosine kinase inhibitor: Ceritinib works by targeting specific tyrosine kinases, which are enzymes involved in cell growth and proliferation. By blocking these enzymes, ceritinib helps to slow down or stop the growth and spread of cancer cells.
- Targeted therapy: Unlike traditional chemotherapy drugs that target rapidly dividing cells throughout the body, ceritinib is a targeted therapy that specifically targets cancer cells with certain genetic mutations.
Uses:
Ceritinib is specifically approved by the US Food and Drug Administration (FDA) for the treatment of NSCLC with the following genetic alterations:
- ALK (anaplastic lymphoma kinase) fusion: This is a specific genetic mutation found in a small percentage of NSCLC cases.
- EGFR (epidermal growth factor receptor) mutations: Ceritinib is only approved for specific types of EGFR mutations that are not sensitive to other EGFR-targeted therapies.
Important Points:
- Not a first-line treatment: Ceritinib is typically used for advanced or metastatic NSCLC that has progressed after treatment with other medications, such as platinum-based chemotherapy or other targeted therapies.
- Genetic testing required: Before starting ceritinib, genetic testing is necessary to confirm the presence of the specific ALK fusion or EGFR mutation that ceritinib targets.
- Potential side effects: Common side effects of ceritinib can include:
- Diarrhea
- Nausea and vomiting
- Fatigue
- Abdominal pain
- Vision problems (blurred vision, light sensitivity)
- Skin rash
- Close monitoring: Patients receiving ceritinib require close monitoring by a healthcare professional to manage side effects and assess treatment response.
Remember: This information is for general knowledge only and should not be a substitute for professional medical advice. Always consult with your doctor or healthcare provider regarding your specific condition, treatment options, and the potential risks and benefits of taking ceritinib. They can assess your individual needs and determine if ceritinib is an appropriate treatment option for you.